Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).

JP Morgan 2009 Healthcare Conference
January 12 - 15, 2009
San Francisco, CA
read more...

BioNetwork East 2009
March 16 - 18, 2009
Naples, Florida
read more...

12-17-2008
Supernus Pharmaceuticals Initiates Phase III Clinical Trial for Epliga™ in Refractory Partial Onset Epileptic Seizures
Once-Per-Day Therapy is Designed to Improve Patient Compliance and Reduce Adverse Events as Compared with Reference Product Trileptal®
    read more...